Release Date: January 31, 2023
Expiration Date: January 31, 2024
Activity Overview
This online, on-demand virtual symposium brings together experts in age-related macular degeneration (AMD) and geographic atrophy (GA). In this educational program, these experts highlight opportunities for improved identification of GA and recognition of patient burden, and they provide a look at investigational therapies that may alter the management of patients with GA.
This educational activity is an archive of the live symposium held on December 16, 2022.
Target Audience
This activity will be directed toward ophthalmologists, optometrists, and other health care professionals involved in the care of patients with AMD and GA.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Define the role for complement system dysregulation in the pathophysiology of GA
- Identify the issues that negatively impact quality of life for patients with GA
- Utilize testing modalities as appropriate for diagnosis and disease progression in patients with GA
- Analyze emerging evidence for the use of targeted therapies in the management of GA
Rishi P. Singh, MD
Staff Physician and President
Cleveland Clinic Martin Hospitals
Cleveland Clinic Florida
Stuart, FL
Disclosures: Grant/Research Support: NGM Biopharma; Consultant: Alcon, AsclepiX, Bausch + Lomb, Genentech, Gyroscope, Novartis, Regeneron.
A. Paul Chous, MA, OD, FAAO
Medical Director
Chous Eyecare Associates
Tacoma, WA
Adjunct Professor of Optometry
Western University of Health Sciences
Pomona, CA
Disclosures: Consultant: AI Optics, American Diabetes Association, Eyenuk, Optomed, Regeneron, VSP, ZeaVision, Zeiss; Speakers’ Bureau: EyePromise, Regeneron, VSP; Royalties: EyePromise.
Mohammad Rafieetary, OD, FAAO, FORS
Optometrist
Charles Retina Institute
Germantown, TN
Disclosures: Consultant: Apellis Therapeutics, Heidelberg Engineering, Iveric Bio, Notal Vision, Novartis, Optos, Regeneron; Speakers’ Bureau: Apellis Therapeutics, Notal Vision, Optos, Regeneron.
Steven Yeh, MD
Professor and Stanley Truhlsen Jr Chair in Ophthalmology
Director - Retina and Uveitis
Truhlsen Eye Institute
University of Nebraska Medical Center
Omaha, NE
Disclosures: Consultant: Adverum, Bausch + Lomb, Regenxbio.
Faculty, Staff, and Planners’ Disclosures
The staff of Physicians’ Education Resource®, LLC, have no relevant financial relationships with ineligible companies.
PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here